Abstract
Islet transplantation is used clinically for replacement of insulin-producing pancreatic beta cells in a subset of patients with type 1 diabetes. Since the publication of successful islet transplantation by the Edmonton group in 2000, over 750 islet transplants have been performed in more than 30 centers worldwide, with ever-improving success rates. However, islet transplantation is limited by the short supply of suitable donor pancreases, as well as the need for immunosuppression to combat rejection of the allograft. This review covers strategies to prevent rejection of islets, and methods are being developed to visualize graft loss and improve survival and function of transplanted beta cells. It is likely that developments in clinical islet transplantation will provide a platform to build new methods for beta cell replacement, including beta cells derived from stem cells or xenotransplantation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abdulreda MH, Faleo G, Molano RD, Lopez-Cabezas M, Molina J, Tan Y, Echeverria OA, Zahr-Akrawi E, Rodriguez-Diaz R, Edlund PK et al (2011) High-resolution, noninvasive longitudinal live imaging of immune responses. Proc Natl Acad Sci USA 108:12863–12868
Abreu JR, Roep BO (2013) Immune monitoring of islet and pancreas transplant recipients. Curr Diab Rep 13:704–712
Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, Ward DC, Ma Y (2010) Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci USA 107:13426–13431
Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86–100
Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M (2001) Insulin production by human embryonic stem cells. Diabetes 50:1691–1697
Bailey-Bucktrout SL, Martinez-Llordella M, Zhou X, Anthony B, Rosenthal W, Luche H, Fehling HJ, Bluestone JA (2013) Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39:949–962
Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M et al (2012) Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care 35:1436–1445
Basmadjian D, Sefton MV, Baldwin SA (1997) Coagulation on biomaterials in flowing blood: some theoretical considerations. Biomaterials 18:1511–1522
Basnet NB, Ide K, Tahara H, Tanaka Y, Ohdan H (2010) Deficiency of N-glycolylneuraminic acid and Galalpha1-3Galbeta1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies. Xenotransplantation 17:440–448
Bellin MD, Barton FB, Heitman A, Harmon JV, Kandaswamy R, Balamurugan AN, Sutherland DE, Alejandro R, Hering BJ (2012) Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant 12:1576–1583
Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Elgue G, Larsson R, Nilsson B et al (1999) Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48:1907–1914
Berman DM, Willman MA, Han D, Kleiner G, Kenyon NM, Cabrera O, Karl JA, Wiseman RW, O’Connor DH, Bartholomew AM et al (2010) Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes 59:2558–2568
Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O’Neil JJ (2000) In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999–8004
Borg DJ, Bonifacio E (2011) The use of biomaterials in islet transplantation. Curr Diab Rep 11:434–444
Brandhorst H, Muehling B, Yamaya H, Henriksnaes J, Carlsson PO, Korsgren O, Brandhorst D (2008) New class of oxygen carriers improves islet isolation from long-term stored rat pancreata. Transpl Proc 40:393–394
Brauker J, Martinson LA, Young SK, Johnson RC (1996) Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. Transplantation 61:1671–1677
Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC (1995) Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 29:1517–1524
Brelje TC, Scharp DW, Lacy PE, Ogren L, Talamantes F, Robertson M, Friesen HG, Sorenson RL (1993) Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132:879–887
Brissova M, Lacik I, Powers AC, Anilkumar AV, Wang T (1998) Control and measurement of permeability for design of microcapsule cell delivery system. J Biomed Mater Res 39:61–70
Broadhead KW, Biran R, Tresco PA (2002) Hollow fiber membrane diffusive permeability regulates encapsulated cell line biomass, proliferation, and small molecule release. Biomaterials 23:4689–4699
Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ (2014) Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes: Targets Ther 7:211–223
Cantley J, Grey ST, Maxwell PH, Withers DJ (2010) The hypoxia response pathway and beta-cell function. Diabetes Obes Metab 12(Suppl 2):159–167
Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S et al (2006) Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 12:304–306
Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M, Voytas DF, Long CR, Whitelaw CB, Fahrenkrug SC (2012) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci USA 109:17382–17387
Chatenoud L (2003) CD3-specific antibody-induced active tolerance: from bench to bedside. Nat Rev Immunol 3:123–132
Chee J, Ko HJ, Skowera A, Jhala G, Catterall T, Graham KL, Sutherland RM, Thomas HE, Lew AM, Peakman M et al (2014) Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes. J Immunol 192:572–580
Cheng K, Ho K, Stokes R, Scott C, Lau SM, Hawthorne WJ, O’Connell PJ, Loudovaris T, Kay TW, Kulkarni RN et al (2010) Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Investig 120:2171–2183
Citro A, Cantarelli E, Maffi P, Nano R, Melzi R, Mercalli A, Dugnani E, Sordi V, Magistretti P, Daffonchio L et al (2012) CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J Clin Investig 122:3647–3651
Collier TO, Anderson JM (2002) Protein and surface effects on monocyte and macrophage adhesion, maturation, and survival. J Biomed Mater Res 60:487–496
Contreras JL, Eckstein C, Smyth CA, Bilbao G, Vilatoba M, Ringland SE, Young C, Thompson JA, Fernandez JA, Griffin JH et al (2004) Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 53:2804–2814
Cooper DK, Hara H, Ezzelarab M, Bottino R, Trucco M, Phelps C, Ayares D, Dai Y (2013) The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation. J Biomed Res 27:249–253
Coronel MM, Stabler CL (2013) Engineering a local microenvironment for pancreatic islet replacement. Curr Opin Biotechnol 24:900–908
Dalvi MP, Umrani MR, Joglekar MV, Hardikar AA (2009) Human pancreatic islet progenitor cells demonstrate phenotypic plasticity in vitro. J Biosci 34:523–528
De Vos P, Vegter D, De Haan BJ, Strubbe JH, Bruggink JE, Van Schilfgaarde R (1996) Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes 45:1102–1107
Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R (2004) Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci USA 101:12634–12639
Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838–3843
Ding Y, Xu D, Feng G, Bushell A, Muschel RJ, Wood KJ (2009) Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes 58:1797–1806
Dionne KE, Colton CK, Yarmush ML (1989) Effect of oxygen on isolated pancreatic tissue. ASAIO Trans 35:739–741
Dolgin E (2014) Encapsulate this. Nat Med 20:9–11
Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–46
Dubois S, Madec AM, Mesnier A, Armanet M, Chikh K, Berney T, Thivolet C (2010) Glucose inhibits angiogenesis of isolated human pancreatic islets. J Mol Endocrinol 45:99–105
Durrbach A, Pestana JM, Pearson T, Vincenti F, Garcia VD, Campistol J, Rial Mdel C, Florman S, Block A, Di Russo G et al (2010) A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 10:547–557
Dwyer KM, Mysore TB, Crikis S, Robson SC, Nandurkar H, Cowan PJ, D’Apice AJ (2006) The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. Transplantation 82:428–432
Eriksson O, Eich T, Sundin A, Tibell A, Tufveson G, Andersson H, Felldin M, Foss A, Kyllonen L, Langstrom B et al (2009) Positron emission tomography in clinical islet transplantation. Am J Transplant 9:2816–2824
Faye A, Van Den Abeele T, Peuchmaur M, Mathieu-Boue A, Vilmer E (1998) Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet 352:1285
Figliuzzi M, Bonandrini B, Silvani S, Remuzzi A (2014) Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World J Stem Cells 6:163–172
Figliuzzi M, Cornolti R, Perico N, Rota C, Morigi M, Remuzzi G, Remuzzi A, Benigni A (2009) Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transpl Proc 41:1797–1800
Fisicaro N, Londrigan SL, Brady JL, Salvaris E, Nottle MB, O’Connell PJ, Robson SC, d’Apice AJ, Lew AM, Cowan PJ (2011) Versatile co-expression of graft-protective proteins using 2A-linked cassettes. Xenotransplantation 18:121–130
Fritschy WM, Strubbe JH, Wolters GH, van Schilfgaarde R (1991) Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts. Diabetologia 34:542–547
Gabardi S, Martin ST, Roberts KL, Grafals M (2011) Induction immunosuppressive therapies in renal transplantation. Am J Health Syst Pharm: AJHP 68:211–218
Gala-Lopez B, Pepper AR, Shapiro AM (2013) Biologic agents in islet transplantation. Curr Diab Rep 13:713–722
Gill RG, Wolf L, Daniel D, Coulombe M (1994) CD4+ T cells are both necessary and sufficient for islet xenograft rejection. Transpl Proc 26:1203
Goto M, Tjernberg J, Dufrane D, Elgue G, Brandhorst D, Ekdahl KN, Brandhorst H, Wennberg L, Kurokawa Y, Satomi S et al (2008) Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation 15:225–234
Gruessner AC (2011) 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud: RDS 8:6–16
Gruessner AC, Sutherland DE, Gruessner RW (2012) Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant 17:100–105
Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:2715–2729
Hart NJ, Chung WJ, Weber C, Ananthakrishnan K, Anderson M, Patek R, Zhang Z, Limesand SW, Vagner J, Lynch RM (2014) Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic beta-cells. ChemBioChem 15:135–145
Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J et al (2005) Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293:830–835
Hering BJ, Wijkstrom M, Graham ML, Hardstedt M, Aasheim TC, Jie T, Ansite JD, Nakano M, Cheng J, Li W et al (2006) Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 12:301–303
Hilderink J, Otto C, Slump C, Lenferink A, Engelse M, van Blitterswijk C, de Koning E, Karperien M, van Apeldoorn A (2013) Label-free detection of insulin and glucagon within human islets of Langerhans using Raman spectroscopy. PLoS ONE 8:e78148
Huurman VA, Hilbrands R, Pinkse GG, Gillard P, Duinkerken G, van de Linde P, van der Meer-Prins PM, der Voort Versteeg-van, Maarschalk MF, Verbeeck K, Alizadeh BZ et al (2008) Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 3:e2435
Ito T, Itakura S, Todorov I, Rawson J, Asari S, Shintaku J, Nair I, Ferreri K, Kandeel F, Mullen Y (2010) Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 89:1438–1445
Jansson L, Carlsson PO (2002) Graft vascular function after transplantation of pancreatic islets. Diabetologia 45:749–763
Ji M, Yi S, Smith-Hurst H, Phillips P, Wu J, Hawthorne W, O’Connell P (2011) The importance of tissue factor expression by porcine NICC in triggering IBMIR in the xenograft setting. Transplantation 91:841–846
Johansson H, Lukinius A, Moberg L, Lundgren T, Berne C, Foss A, Felldin M, Kallen R, Salmela K, Tibell A et al (2005) Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 54:1755–1762
Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH, Kim SK (2007) Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318:806–809
Keenan HA, Sun JK, Levine J, Doria A, Aiello LP, Eisenbarth G, Bonner-Weir S, King GL (2010) Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59:2846–2853
Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S et al (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598–2608
Kheradmand T, Wang S, Gibly RF, Zhang X, Holland S, Tasch J, Graham JG, Kaufman DB, Miller SD, Shea LD et al (2011) Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials 32:4517–4524
Kim JH, Jin SM, Oh SH, Lee S, Oh BJ, Kim SK, Suh S, Lee JH, Jung HS, Lee MS et al (2012) Counting small hypointense spots confounds the quantification of functional islet mass based on islet MRI. Am J Transplant 12:1303–1312
Kim SJ, Doudet DJ, Studenov AR, Nian C, Ruth TJ, Gambhir SS, McIntosh CH (2006) Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival. Nat Med 12:1423–1428
Koh A, Senior P, Salam A, Kin T, Imes S, Dinyari P, Malcolm A, Toso C, Nilsson B, Korsgren O et al (2010) Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 89:465–471
Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-Hora M, Kodama T, Tanaka S, Bluestone JA, Takayanagi H (2014) Pathogenic conversion of Foxp3(+) T cells into TH17 cells in autoimmune arthritis. Nat Med 20:62–68
Koulmanda M, Laufer TM, Auchincloss H Jr, Smith RN (2004) Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response. Xenotransplantation 11:525–530
Kriz J, Jirak D, Girman P, Berkova Z, Zacharovova K, Honsova E, Lodererova A, Hajek M, Saudek F (2005) Magnetic resonance imaging of pancreatic islets in tolerance and rejection. Transplantation 80:1596–1603
Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J et al (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443–452
Lanza RP, Butler DH, Borland KM, Staruk JE, Faustman DL, Solomon BA, Muller TE, Rupp RG, Maki T, Monaco AP et al (1991) Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA 88:11100–11104
Lee DY, Nam JH, Byun Y (2004) Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocyte and cytokine attacks. J Biomater Sci Polym Ed 15:753–766
Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB (1999) Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5:1298–1302
Lin CC, Anseth KS (2011) Cell-cell communication mimicry with poly(ethylene glycol) hydrogels for enhancing beta-cell function. Proc Natl Acad Sci USA 108:6380–6385
Loudovaris T, Mandel TE, Charlton B (1996) CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells. Transplantation 61:1678–1684
Lowe MC, Badell IR, Turner AP, Thompson PW, Leopardi FV, Strobert EA, Larsen CP, Kirk AD (2013) Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy. Am J Transplant 13:312–319
Ludwig B, Rotem A, Schmid J, Weir GC, Colton CK, Brendel MD, Neufeld T, Block NL, Yavriyants K, Steffen A et al (2012) Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci USA 109:5022–5027
Ludwig B, Zimerman B, Steffen A, Yavriants K, Azarov D, Reichel A, Vardi P, German T, Shabtay N, Rotem A et al (2010) A novel device for islet transplantation providing immune protection and oxygen supply. Horm Metab Res 42:918–922
Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389–1394
Lutz AJ, Li P, Estrada JL, Sidner RA, Chihara RK, Downey SM, Burlak C, Wang ZY, Reyes LM, Ivary B et al (2013) Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 20:27–35
Maki T, Ubhi CS, Sanchez-Farpon H, Sullivan SJ, Borland K, Muller TE, Solomon BA, Chick WL, Monaco AP (1991) Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation 51:43–51
Marino E, Walters SN, Villanueva JE, Richards JL, Mackay CR, Grey ST (2014) BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Eur J Immunol 44:983–993
Mattsson G, Jansson L, Carlsson PO (2002) Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51:1362–1366
Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R, Ostraat O, Salmela K, Tibell A, Tufveson G et al (2002) Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360:2039–2045
Moberg L, Korsgren O, Nilsson B (2005) Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. Clin Exp Immunol 142:125–131
Monti P, Scirpoli M, Maffi P, Ghidoli N, De Taddeo F, Bertuzzi F, Piemonti L, Falcone M, Secchi A, Bonifacio E (2008) Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Investig 118:1806–1814
Moritz W, Meier F, Stroka DM, Giuliani M, Kugelmeier P, Nett PC, Lehmann R, Candinas D, Gassmann M, Weber M (2002) Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J 16:745–747
Morris PJ, Russell NK (2006) Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Transplantation 81:1361–1367
Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE (2006) Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177:2080–2087
Naziruddin B, Iwahashi S, Kanak MA, Takita M, Itoh T, Levy MF (2014) Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation. Am J Transplant 14:428–437
Niclauss N, Morel P, Berney T (2014) Has the gap between pancreas and islet transplantation closed? Transplantation 98:593–599
Nilsson B, Ekdahl KN, Korsgren O (2011) Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant 16:620–626
O’Connell PJ, Cowan PJ, Hawthorne WJ, Yi S, Lew AM (2013a) Transplantation of xenogeneic islets: are we there yet? Curr Diab Rep 13:687–694
O’Connell PJ, Holmes-Walker DJ, Goodman D, Hawthorne WJ, Loudovaris T, Gunton JE, Thomas HE, Grey ST, Drogemuller CJ, Ward GM et al (2013b) Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. Am J Transplant 13:1850–1858
O’Shea GM, Sun AM (1986) Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes 35:943–946
Olack BJ, Jaramillo A, Benshoff ND, Kaleem Z, Swanson CJ, Lowell JA, Mohanakumar T (2002) Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway. Xenotransplantation 9:393–401
Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B (2002) Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51:1779–1784
Padera RF, Colton CK (1996) Time course of membrane microarchitecture-driven neovascularization. Biomaterials 17:277–284
Pagliuca FW, Millman JR, Gurtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, Melton DA (2014) Generation of functional human pancreatic beta cells in vitro. Cell 159:428–439
Pedraza E, Coronel MM, Fraker CA, Ricordi C, Stabler CL (2012) Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc Natl Acad Sci USA 109:4245–4250
Piemonti L, Everly MJ, Maffi P, Scavini M, Poli F, Nano R, Cardillo M, Melzi R, Mercalli A, Sordi V et al (2013) Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes 62:1656–1664
Porat S, Weinberg-Corem N, Tornovsky-Babaey S, Schyr-Ben-Haroush R, Hija A, Stolovich-Rain M, Dadon D, Granot Z, Ben-Hur V, White P et al (2011) Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab 13:440–449
Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L et al (2010) Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation 90:1595–1601
Putnam AL, Safinia N, Medvec A, Laszkowska M, Wray M, Mintz MA, Trotta E, Szot GL, Liu W, Lares A et al (2013) Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant 13:3010–3020
Qi M, Kinzer K, Danielson KK, Martellotto J, Barbaro B, Wang Y, Bui JT, Gaba RC, Knuttinen G, Garcia-Roca R et al (2014) Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience. Acta Diabetol 51:833–843
Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, O’Dwyer S, Quiskamp N, Mojibian M, Albrecht T et al (2014) Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol 32:1121–1133
Rickels MR, Liu C, Shlansky-Goldberg RD, Soleimanpour SA, Vivek K, Kamoun M, Min Z, Markmann E, Palangian M, Dalton-Bakes C et al (2013) Improvement in beta-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes 62:2890–2897
Risbud MV, Bhargava S, Bhonde RR (2003) In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: implications of low molecular weight cut-off. J Biomed Mater Res, Part A 66:86–92
Rothstein DM, Sayegh MH (2003) T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196:85–108
Sakata N, Yoshimatsu G, Tsuchiya H, Aoki T, Mizuma M, Motoi F, Katayose Y, Kodama T, Egawa S, Unno M (2013) Imaging of transplanted islets by positron emission tomography, magnetic resonance imaging, and ultrasonography. Islets 5:179–187
Salthouse TN (1984) Some aspects of macrophage behavior at the implant interface. J Biomed Mater Res 18:395–401
Salvay DM, Rives CB, Zhang X, Chen F, Kaufman DB, Lowe WL Jr, Shea LD (2008) Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation 85:1456–1464
Samy KP, Martin BM, Turgeon NA, Kirk AD (2014) Islet cell xenotransplantation: a serious look toward the clinic. Xenotransplantation 21:221–229
Sato Y, Endo H, Okuyama H, Takeda T, Iwahashi H, Imagawa A, Yamagata K, Shimomura I, Inoue M (2011) Cellular hypoxia of pancreatic beta-cells due to high levels of oxygen consumption for insulin secretion in vitro. J Biol Chem 286:12524–12532
Scharp DW, Marchetti P (2014) Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev 67–68:35–73
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238
Shapiro AM, Ricordi C (2004) Unraveling the secrets of single donor success in islet transplantation. Am J Transplant 4:295–298
Shimoda M, Chen S, Noguchi H, Matsumoto S, Grayburn PA (2010) In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver. Diabetologia 53:1669–1679
Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M et al (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950–951
Sorenson RL, Brelje TC, Roth C (1993) Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 133:2227–2234
Stendahl JC, Kaufman DB, Stupp SI (2009) Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant 18:1–12
Sullivan SJ, Maki T, Borland KM, Mahoney MD, Solomon BA, Muller TE, Monaco AP, Chick WL (1991) Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 252:718–721
Suszynski TM, Rizzari MD, Scott WE, Eckman PM, Fonger JD, John R, Chronos N, Tempelman LA, Sutherland DE, Papas KK (2013) Persufflation (gaseous oxygen perfusion) as a method of heart preservation. J Cardiothorac Surg 8:105
Sutherland DE, Sibley R, Xu XZ, Michael A, Srikanta AM, Taub F, Najarian J, Goetz FC (1984) Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Am Physicians 97:80–87
Teo AK, Wagers AJ, Kulkarni RN (2013) New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism. Cell Metab 18:775–791
Thompson P, Badell IR, Lowe M, Cano J, Song M, Leopardi F, Avila J, Ruhil R, Strobert E, Korbutt G et al (2011) Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant 11:2593–2602
Tibell A, Rafael E, Wennberg L, Nordenstrom J, Bergstrom M, Geller RL, Loudovaris T, Johnson RC, Brauker JH, Neuenfeldt S et al (2001) Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans. Cell Transplant 10:591–599
Toso C, Isse K, Demetris AJ, Dinyari P, Koh A, Imes S, Kin T, Emamaullee J, Senior P, Shapiro AM (2009) Histologic graft assessment after clinical islet transplantation. Transplantation 88:1286–1293
Turgeon NA, Avila JG, Cano JA, Hutchinson JJ, Badell IR, Page AJ, Adams AB, Sears MH, Bowen PH, Kirk AD et al (2010) Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant 10:2082–2091
van der Windt DJ, Bottino R, Casu A, Campanile N, Smetanka C, He J, Murase N, Hara H, Ball S, Loveland BE et al (2009) Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 9:2716–2726
Vantyghem MC, Defrance F, Quintin D, Leroy C, Raverdi V, Prevost G, Caiazzo R, Kerr-Conte J, Glowacki F, Hazzan M et al (2014) Treating diabetes with islet transplantation: lessons from the past decade in Lille. Diabetes Metab 40:108–119
Vendrame F, Pileggi A, Laughlin E, Allende G, Martin-Pagola A, Molano RD, Diamantopoulos S, Standifer N, Geubtner K, Falk BA et al (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59:947–957
Veriter S, Gianello P, Dufrane D (2013) Bioengineered sites for islet cell transplantation. Curr Diab Rep 13:745–755
Walsh PT, Taylor DK, Turka LA (2004) Tregs and transplantation tolerance. J Clin Investig 114:1398–1403
Wang P, Yigit MV, Medarova Z, Wei L, Dai G, Schuetz C, Moore A (2011) Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantation. Diabetes 60:565–571
Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M (2002) Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14:592–600
Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, Hughes S, Johnson P, Wood KJ (2013) Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model. Transplantation 96:707–716
Xie D, Smyth CA, Eckstein C, Bilbao G, Mays J, Eckhoff DE, Contreras JL (2005) Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation. Biomaterials 26:403–412
Xu X, D’Hoker J, Stange G, Bonne S, De Leu N, Xiao X, Van de Casteele M, Mellitzer G, Ling Z, Pipeleers D et al (2008) Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132:197–207
Yamasaki T, Inoue K, Hayashi H, Gu Y, Setoyama H, Ida J, Cui W, Kawakami Y, Kogire M, Imamura M (1998) Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts. Cell Transplant 7:403–406
Yazaki S, Iwamoto M, Onishi A, Miwa Y, Hashimoto M, Oishi T, Suzuki S, Fuchimoto D, Sembon S, Furusawa T et al (2012) Production of cloned pigs expressing human thrombomodulin in endothelial cells. Xenotransplantation 19:82–91
Yi S, Feng X, Hawthorne WJ, Patel AT, Walters SN, O’Connell PJ (2002) CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells. Transplantation 73:437–446
Zhang N, Richter A, Suriawinata J, Harbaran S, Altomonte J, Cong L, Zhang H, Song K, Meseck M, Bromberg J et al (2004) Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53:963–970
Acknowledgments
The authors thank Mr. William Stanley for assistance with figures. This work was funded by a Program Grant (APP1037321), fellowship (HET), and Clinical Centre of Research Excellence: Clinical Science in Diabetes (APP454461) from the National Health and Medical Research Council of Australia; the Department of Health and Ageing, Commonwealth of Australia administered by the Juvenile Diabetes Research Foundation; and the Susan Alberti Medical Research Foundation. The St. Vincent’s Institute receives support from the Operational Infrastructure Support Scheme of the Government of Victoria.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Thomas, H.E., Graham, K.L., Loudovaris, T., Kay, T.W.H. (2016). Regenerative Medicine: Clinical Islet Transplantation. In: A. Hardikar, A. (eds) Pancreatic Islet Biology. Stem Cell Biology and Regenerative Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-45307-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-45307-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45305-7
Online ISBN: 978-3-319-45307-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)